Table 3.
Functional parameter of improvement, indicated by + for all measurements except MLHF, in which lower scores reflect less limitation |
Increased survival preference at 3 months (N=86) |
Decreased survival preference at 3 months (N=50) |
Total number with changing preferences and repeated parameter measurement 86 + 50 = 136 |
P value |
---|---|---|---|---|
Patient global health | +19 (28) | +8 (27) | 95 | 0.126 |
visual analog score | ||||
Breathing | +12 (31) | +9 (22) | 49 | 0.56 |
visual analog score | ||||
Freedom from worst | +25 (31) | +8 (23) | 92 | 0.0065 |
symptom | ||||
visual analog score | ||||
MLHF | − 22 (23) | −10 (25) | 94 | 0.014 |
6-minute walk, ft | +426 (403) | +329 (546) | 59 | 0.27 |
Improvement in at least | 83% | 59% | 96 | 0.011 |
2 of above* |
Table entries are mean (standard deviation) except last row. P-values from Wilcoxon rank sum tests except last, from likelihood ratio chi square.
Defined as increase at least 10 for visual analog scores, decrease at least 5 for MLHF, increase at least 50 feet for walk.